Suppr超能文献

益生菌可调节花粉季节中日柏花粉症患者的肠道微生物群和健康状况。

Probiotics modulate gut microbiota and health status in Japanese cedar pollinosis patients during the pollen season.

机构信息

Technical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, 241-0023, Japan.

Functional Foods Forum, University of Turku, 20014, Turku, Finland.

出版信息

Eur J Nutr. 2017 Oct;56(7):2245-2253. doi: 10.1007/s00394-016-1264-3. Epub 2016 Jul 13.

Abstract

BACKGROUND

Japanese cedar pollinosis (JCP) is a challenging public health problem in Japan. Altered gut microbiota is associated with several diseases, including allergic diseases. However, only a few studies have focused on JCP and the underlying mechanisms for probiotic effects remain unclear. In addition, this study is the first observation of the correlation between the gut microbiota and blood lipid in JCP.

METHODS

Faecal samples from JCP subjects were collected before and after treatment with (n = 14) and without (n = 11) LGG-TMC0356-fermented milk for 10 weeks. Gut microbiota composition was characterized from faecal DNA using sequencing of 16S rRNA genes.

RESULTS

16S rRNA-based operational taxonomic unit clustering of the microbiota revealed that LGG-TMC0356-fermented milk significantly altered gut microbiota after 10 weeks of milk consumption, and eight dominant genera of microbes were detected. During the JCP season, the Bacteroidetes/Firmicutes ratio, when compared to baseline, was significantly decreased in subjects at end of the study. Bacteroidetes showed positive correlation with LDL- and HDL-cholesterol levels, whereas Firmicutes showed negative correlation with total cholesterol, LDL- and HDL- cholesterol.

CONCLUSIONS

The altered gut microbiota through supplementation of fermented milk containing the study probiotics may be a prospective target for protection against JCP, with beneficial effects on blood lipid levels.

摘要

背景

日本扁柏花粉症(JCP)是日本一个具有挑战性的公共卫生问题。肠道微生物群的改变与包括过敏疾病在内的多种疾病有关。然而,只有少数研究关注 JCP,益生菌作用的潜在机制仍不清楚。此外,本研究首次观察到 JCP 患者的肠道微生物群与血液脂质之间的相关性。

方法

在使用(n=14)和不使用(n=11)LGG-TMC0356 发酵乳治疗 10 周前后,从 JCP 患者的粪便样本中收集粪便样本。使用 16S rRNA 基因测序对粪便 DNA 进行肠道微生物组成特征分析。

结果

基于 16S rRNA 的微生物操作分类单元聚类显示,LGG-TMC0356 发酵乳在饮用 10 周后显著改变了肠道微生物群,检测到了 8 个主要的微生物属。在 JCP 季节,与基线相比,研究结束时受试者的拟杆菌门/厚壁菌门比值显著降低。拟杆菌门与 LDL-和 HDL-胆固醇水平呈正相关,而厚壁菌门与总胆固醇、LDL-和 HDL-胆固醇呈负相关。

结论

通过补充含有研究益生菌的发酵乳来改变肠道微生物群可能是预防 JCP 的一个有前景的目标,对血液脂质水平有有益的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验